PeptideCrafters The anti-inflammatory peptide Ac-SDKP is a naturally occurring tetrapeptide with significant therapeutic potential. Research indicates that Ac-SDKP exhibits potent anti-inflammatory and anti-fibrotic properties, making it a subject of interest in managing various diseases. This peptide plays a role in regulating immune responses and promoting angiogenesis, contributing to its multifaceted biological activity.
Ac-SDKP, chemically known as N-acetyl-seryl-aspartyl-lysyl-proline, is an endogenous molecule found in mammalian organs, plasma, and urine. It is derived from thymosin beta 4 and is hydrolyzed by enzymes like angiotensin-converting enzyme (ACE). Its tetrapeptide structure is crucial to its biological functions. Studies have demonstrated its presence and activity in various physiological contexts, including cardiovascular health and immune system regulation.
The therapeutic applications of Ac-SDKP are broad, stemming from its core properties. Its anti-inflammatory effects are particularly notable in conditions such as hypertension and cardiovascular diseases, where it can help mitigate tissue damage and improve organ function. Research has explored its role in conditions affecting the heart, kidneys, lungs, and in managing diabetes.
Furthermore, Ac-SDKP has shown promise in promoting tissue repair and regenerationAc-SDKP peptide improves functional recovery following .... Its pro-angiogenic effects are beneficial in conditions requiring new blood vessel formation, such as wound healing and recovery from ischemic eventsThe anti-inflammatory peptide Ac-SDKP is released from .... Studies have also highlighted its potential in improving functional recovery after spinal cord injury (SCI) by reducing inflammation and protecting motor neurons.
A key attribute of Ac-SDKP is its anti-fibrotic action. Fibrosis, the excessive formation of scar tissue, is a common pathological process in many chronic diseases. Ac-SDKP has been shown to inhibit collagen production by attenuating endoplasmic reticulum stress and related signaling pathways. This mechanism is relevant in conditions like myocardial infarction, where it can help prevent excessive scarring and preserve cardiac function.Source, Synthetic; Molecular Weight, 487.51 ; Protein Sequence, Ac-Ser-Asp-Lys-Pro-OH ; Purity, > 95% ; Storage, Shipped at 4°C. Store at -20°C for one year. Ac-SDKP-conjugated self-assembling peptides are also being investigated for their potential to decelerate adverse remodeling after heart injury.
Beyond its systemic effects, Ac-SDKP influences cellular processesSource, Synthetic; Molecular Weight, 487.51 ; Protein Sequence, Ac-Ser-Asp-Lys-Pro-OH ; Purity, > 95% ; Storage, Shipped at 4°C. Store at -20°C for one year.. It is known to inhibit the proliferation of hematopoietic stem cells, thereby protecting hematopoiesis, the process of blood cell formation.Ac-SDKP (Thymosin Beta 4 Fragment (1–4), Goralatide)is an endogenous tetrapeptide derivativethat is the N-acetylated derivative of the fragment composed ... This regulatory role suggests potential applications in managing conditions related to blood cell disorders or in contexts where stem cell activity needs to be modulated, such as in radiation-induced damage.
Ongoing research continues to uncover the full spectrum of Ac-SDKP's capabilities. Its synthetic derivatives, such as Ac-SDKP trifluoroacetate, are available for research purposes. The peptide's involvement in angiogenesis and immune response regulation makes it a candidate for further investigation in inflammatory diseases, autoimmune conditions, and regenerative medicine. While its mechanisms of action are still being elucidated, particularly its receptor interactions, the consistent findings of anti-inflammatory, anti-fibrotic, and pro-angiogenic effects underscore its therapeutic promise. Future research will likely focus on optimizing delivery methods, understanding its precise molecular targets, and translating these findings into clinical applications.
Join the newsletter to receive news, updates, new products and freebies in your inbox.